Clinical Trials Of Orange is categorized under Research and Development Laboratories in Fullerton, CA and active since 2001.
Clinical Trials Of Orange was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Susan Wallace at the company’s single location by writing to 433 West Bastanchury Road, Fullerton, California CA 92835 or by phoning (714) 223-9433. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Clinical Trials Of Orange |
Contact Person: | Susan Wallace |
Address: | 433 West Bastanchury Road, Fullerton, California 92835 |
Phone Number: | (714) 223-9433 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Research and Development Laboratories |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Clinical Trials Of Orange was started in 2001 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Susan Wallace for inquiries that concern Clinical Trials Of Orange by calling the company number (714) 223-9433, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Trials Of Orange can be found at the coordinates as well as the street address 433 West Bastanchury Road in Fullerton, California 92835.
For its online presence, you may visit Clinical Trials Of Orange’s website at and engage with its social media outlets through on Twitter and on Facebook.